Skip to Content


In the US, Indacaterol (indacaterol systemic) is a member of the drug class adrenergic bronchodilators and is used to treat COPD, Maintenance.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


β₂-Sympathomimetic agent

Treatment of asthma and COPD

Chemical Names

2(1H)-Quinolinone, 5-{(1R)-2-[(5,6-dietyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyetyl}-8-hydroxy- (USAN)

5-{(1R)-2-[(5,6-dietyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyetyl}-8-hydroxyquinolin-2(1H)-one (WHO)

Foreign Names

  • Indacaterolum (Latin)
  • Indacaterol (German)
  • Indacatérol (French)
  • Indacaterol (Spanish)

Generic Names

  • Indacaterol (OS: USAN, BAN)
  • QAB149 (IS)
  • UNII-8OR09251MQ (IS)
  • Indacaterol Maleate (OS: USAN, BANM, JAN)
  • QAB149-AFA (IS)
  • R788 free acid (IS)
  • R935788 free acid (IS)

Brand Names

  • Arcapta 150 mcg
    Farmanova, Turkey
  • Hirobriz
    Novartis, Croatia (Hrvatska); Novartis Europharm, Slovenia
  • Horibriz
    Novartis, Poland
  • Ombrez
    Novartis, Lebanon
  • Onbrez
    Novartis, Bosnia & Herzegowina; Novartis, Egypt; Novartis, Slovakia; Novartis, Tunisia; Novartis Europharm, Cyprus; Novartis PHarma Services Inc., Serbia
  • Onbrez 300 µg
    Novartis, Hungary
  • Onbrez Breezhaler
    Novartis, Turkey
  • Onbrize
    Novartis, Chile; Novartis, Ecuador; Novartis, Uruguay
  • Onbrize Cort [+ Budesonide]
    Novartis, Argentina
  • Oslif
    Novartis, Lithuania; Novartis, Poland; Novartis Europharm, Slovenia
  • Oslif Breezhaler
    Novartis Europharm Limited, Latvia
  • Ultibro [+ Glycopyrronium Bromide]
    Novartis, Bosnia & Herzegowina; Novartis, Brazil; Novartis, Chile; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Indonesia; Novartis, Lithuania; Novartis, Mauritania; Novartis, New Zealand; Novartis, Poland; Novartis Europharm, Slovenia; Novartis Europharm Limited, Latvia; Novartis Pharma, Peru; Novartis PHarma Services Inc., Serbia; Novartis Singapore, Singapore
  • Ultibro 110mcg/50mcg [+ Glycopyrronium Bromide]
    Novartis, Oman
  • Ultibro 85 µg/43 µg [+ Glycopyrronium Bromide]
    Novartis, Hungary
  • Ulunar [+ Glycopyrronium Bromide]
    Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Poland
  • Ulunar [+ Glycopyrronium]
    Sanfer, Mexico
  • Xoterna [+ Glycopyrronium Bromide]
    Novartis, Lithuania
  • Xoterna [+ Glycopyrronium]
    Novartis, Croatia (Hrvatska)
  • Arcapta
    Sunovion, United States
  • Hirobriz
    Novartis, Denmark; Novartis, Lithuania; Novartis, Sweden; Novartis Europharm, Greece; Rovi, Spain
  • Hirobriz Breezhaler
    Novartis, Estonia; Novartis, Netherlands; Novartis, Portugal
  • Onbrez
    Novartis, Belgium; Novartis, Czech Republic; Novartis, Denmark; Novartis, Estonia; Novartis, Finland; Novartis, France; Novartis, Greece; Novartis, Hong Kong; Novartis, Indonesia; Novartis, Ireland; Novartis, Japan; Novartis, South Korea; Novartis, Lithuania; Novartis, Latvia; Novartis, Macedonia; Novartis, Malaysia; Novartis, Norway; Novartis, New Zealand; Novartis, Poland; Novartis, Sweden; Novartis, Thailand; Novartis Europharm, Slovenia; Novartis Europharm Limited, Iceland; Novartis Farmaceutica, Spain; Novartis Farmaceutica, Georgia; Novartis Healthcare, Philippines; Novartis Pharma, Germany; Novartis Pharma, Russian Federation; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals, Netherlands; Novartis Pharmaceuticals UK, United Kingdom; Novartis Singapore, Singapore
  • Onbrez 0.15mg
    Novartis Pharma, Switzerland
  • Onbrez 0.3mg
    Novartis Pharma, Switzerland
  • Onbrez 150 µg
    Novartis, Hungary
  • Onbrez 150mcg
    Novartis, Israel; Novartis, Luxembourg
  • Onbrez 300mcg
    Novartis, Israel; Novartis, Luxembourg
  • Onbrez Breezhaler
    Novartis, Portugal; Novartis AH, South Africa; Novartis Europharm, Romania
  • Onbrez Breezhaler 150 µg
    Beijing Novartis Pharma Co., Ltd., China; Novartis, Oman
  • Onbrez Breezhaler 300 µg
    Novartis, Oman
  • Onbrize
    Novartis, Argentina; Novartis, Colombia
  • Oslif
    Ferrer Internacional, Spain; Novartis, Estonia; Novartis, Sweden; Novartis Europharm, Greece; Novartis Pharmaceuticals, Netherlands
  • Oslif Breezhaler
    Novartis, Portugal
  • Ultibro [+ Glycopyrronium Bromide]
    Novartis, Argentina; Novartis, Belgium; Novartis, Czech Republic; Novartis, Denmark; Novartis, Estonia; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Ireland; Novartis, Israel; Novartis, Japan; Novartis, Luxembourg; Novartis, Netherlands; Novartis, Norway; Novartis, Portugal; Novartis, Sweden; Novartis, Slovakia; Novartis Europharm, Greece; Novartis Europharm, Romania; Novartis Farmaceutica, Spain; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom
  • Ultibro 110/50 [+ Glycopyrronium Bromide]
    Novartis Pharmaceuticals, Australia
  • Ultibro 110mcg/50mcg [+ Glycopyrronium Bromide]
    Novartis Pharma, Switzerland
  • Ultibro 85 µg/43 µg [+ Glycopyrronium Bromide]
    Novartis Europharm, Austria
  • Ultibro 85 Mikrogramm/43 Mikrogramm [+ Glycopyrronium Bromide]
    Novartis Pharma, Germany
  • Ulunar [+ Glycopyrronium Bromide]
    Novartis, Netherlands; Novartis, Sweden; Rovi, Spain
  • Ulunar [+ Glycopyrronium]
    Novartis, Estonia; Novartis Europharm, Greece; UCB Pharma, Germany
  • Utibron [+ Glycopyrronium Bromide]
    Sunovion, United States
  • Xoterna [+ Glycopyrronium Bromide]
    Ferrer Internacional, Spain; Gador, Argentina; Novartis, Sweden
  • Xoterna [+ Glycopyrronium]
    Novartis, Estonia; Novartis, Netherlands; Novartis, Poland; Novartis, Portugal; Novartis Europharm, Greece


BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.